)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Avecho Biotechnology
Avecho Biotechnology (AVE) investor relations material
Avecho Biotechnology Q4 2025 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 TU earnings summary28 Jan, 2026
Executive summary
Phase III CBD insomnia trial nearing completion of interim analysis recruitment, with 190 of 210 patients dosed as of December 2025; interim analysis expected in H1 2026.
$2.5 million raised in October 2025 to accelerate commercial manufacturing and support regulatory submissions for the CBD insomnia product.
US and European patent applications for the CBD TPM® soft-gel capsule have been allowed, with formal grants expected by end of FY26, providing protection until at least 2040.
Financial highlights
Cash balance at 31 December 2025 was $4.7 million, with an estimated $1.8 million in R&D tax credits forecast for Q2 2026.
$1,846K invested in R&D during the quarter (YTD: $4,293K), primarily for the Phase III trial and manufacturing activities.
Net cash used in operating activities for the quarter was $(2,214)K.
$2.5 million raised via equity placement; net cash from financing activities was $2,291K for the quarter.
Payments to related parties totaled $67K for the quarter.
Outlook and guidance
Interim analysis of the Phase III trial is targeted for completion in the first half of 2026, representing a major clinical and commercial milestone.
Accelerated manufacturing program aims to enable rapid TGA submission and commercial supply following successful trial results.
Quarterly operating costs are expected to decrease in coming months as significant trial and support costs were concentrated in the December quarter.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Avecho Biotechnology earnings date
Q1 202629 Apr, 2026
Avecho Biotechnology
Next Avecho Biotechnology earnings date
Q1 202629 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Avecho Biotechnology Limited is an Australian pharmaceutical company focused on drug delivery systems. The company develops proprietary formulations that enhance the solubility and absorption of active pharmaceutical ingredients using lipid-based delivery platforms. Its technologies are applied in human health, animal health, and topical therapeutics. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage